OCULAR THERAPEUTIX, INC (OCUL) Net margin 2016–2025
OCULAR THERAPEUTIX, INC (OCUL) net profit margin by fiscal year — reported net income divided by reported revenue.
-511.9%FY2025 · since FY2016: -2369.0% → -511.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -511.9% | -208.2 pp |
| FY2024 | -303.7% | -165.5 pp |
| FY2023 | -138.1% | -0.2 pp |
| FY2022 | -138.0% | -122.9 pp |
| FY2021 | -15.1% | +879.2 pp |
| FY2020 | -894.3% | +1149.0 pp |
| FY2019 | -2043.3% | +970.6 pp |
| FY2018 | -3014.0% | +282.2 pp |
| FY2017 | -3296.2% | -927.2 pp |
| FY2016 | -2369.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More OCUL financial trends
OCUL RevenueOCUL Net incomeOCUL Gross profitOCUL Gross marginOCUL Operating incomeOCUL Operating marginOCUL Operating cash flowOCUL Free cash flowOCUL Capital expendituresOCUL Return on equityOCUL Stock buybacksOCUL Dividends paidOCUL Total assetsOCUL Total liabilitiesOCUL Shareholders’ equityOCUL overview →